Director Omnibus Decision – 12 IPRsMay 19, 2026
Notice of Decisions on Institution — 2026-05-19
Patent Trial and Appeal Board
Total Proceedings
12
in this notice
Total Denied
7
discretionary + merits
Total Instituted
5
trial granted
Grant Rate
42%
58% denial rate
Trial Instituted· 5 proceedings
PGR2026-00012IPR2026-00162IPR2026-00160IPR2026-00159IPR2026-00163
Discretionary Denial· 6 proceedings
IPR2026-00201PGR2026-00021IPR2026-00202IPR2026-00221IPR2026-00223IPR2026-00200
Institution Denied· 1 proceeding
IPR2026-00151
Note
The USPTO Director issued an omnibus institution notice covering multiple proceedings. Written opinions may follow for selected cases.
- PTAB Director Review · Oct. 8, 2026Notice of Decisions on Institution — 2026-10-08
- PTAB Director Review · Sept. 24, 2026Biocon Biologics Limited et al. v. Regeneron Pharmaceuticals, Inc.
- PTAB Director Review · Sept. 23, 2026Notice of Decisions on Institution — 2026-09-23
- PTAB Director Review · Sept. 23, 2026Nearmap US, Inc. v. Eagle View Technologies, Inc.
- PTAB Director Review · Aug. 25, 2026Aesthetic Management Partners, LLC and Aesthetic Management Partners, Inc. v. HydraFacial LLC